Amid Expected Enhertu Entry, Chinese Domestic ADC Developers Race To Market

'Fast-Follower' Strategy?

 
• By Dexter Jie Yan
  
Chinese developers are flocking to ADC drugs after seeing chances of blockbuster success.
At least 12 HER2-targeted ADCs in clinical studies in China • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia